Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 22 (RPL29P22)

Target: RPL29P22
Molecular classification: Other (pseudogene; not a member of canonical protein families such as receptors, enzymes, or channels)

Overview

Ribosomal protein L29 pseudogene 22 (RPL29P22) is a processed pseudogene related to the ribosomal protein L29 gene family. Pseudogenes are DNA sequences that resemble functional genes but are generally not expressed as proteins and do not participate in normal cellular physiology. RPL29P22 has no known biological or disease-related roles, is not used as a drug target or biomarker, and does not encode a functional receptor, enzyme, or transporter

Other names: Ribosomal Protein L29 Pseudogene 22RPL29P22

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 22 (RPL29P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 22 (RPL29P22).

Explore the full profile